Shikhar Cons. (526883)
Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹154 |
| Market Cap | ₹9.52 Cr |
| P/E Ratio | 0 |
| ROCE | -3.27% |
| ROE | -5.62% |
| Dividend Yield | 0% |
| Profit Growth | 0% |
| Debt/Equity | — |
| Sales Growth | 0% |
| 52-Week Range | ₹6.57 — ₹154 |
| Sector | Finance |
| Book Value | ₹4.7 |
AI Analysis
AI-generated, general educational analysis — not personal investment advice.
Looking at Shikhar Cons., I struggle to call myself an investor in this stock. At ₹154, market cap ₹10 crore, the market is placing a price tag 32.8 times book value, yet the book value is just ₹4.70. Meanwhile the company earns negative returns: ROE -5.62%, ROCE -3.27%. In the latest quarter, sales are ₹0 crore and net profit is about -₹0 crore. There is zero sales growth, zero profit growth, zero dividend, and a Piotroski F-score of 2 out of 9. Graham taught me to buy dollar bills for 50 cents; here the market is asking many rupees for a company that is losing money. The 52-week range of ₹3.94-₹154.00 shouts speculation, not compounding. Without revenue or profit, there is no earnings power to value; a P/E of 0.00 signals no earnings, not cheapness. As an NBFC, I would want to know loan book quality and debt exposure, but debt/equity is N/A, promoter holding is N/A, and the FairStock score says insufficient data. No moat exists in a shell with negative ROE. If forced into a category, it can only be a speculative turnaround, and even then I see no evidence of a turnaround. My Benjamin Graham value screens would reject it immediately. A 2/9 Piotroski score confirms poor financial health. I need margin of safety; at 33 times book with negative returns, there is none. This belongs in the too-hard pile. I would not buy it; I cannot recommend it; I would wait for either a real business with positive earnings or a price far below book.
The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer